iiinova — where your digital self keeps evolving

A pilot phase IIa randomized, placebo-controlled, double-blind trial of intravenous human pluripotent adipose-derived stem cells (PASCs) in Parkinson’s disease: The REPOSE study @celltransplant1992.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #neurodegenerativedisease

000

Jen L, PhD @drjkyl.bsky.social · 19m

Sensitivity and specificity of FDG-PET in detecting abdominopelvic disease in desmoplastic small round cell tumor Rare Tumors @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #sarcoma #medicalimaging #cancer #oncology #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 21m

Extragastrointestinal stromal tumor involving the adrenal region: A rare case report Rare Tumors @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #GISTs #cancer #oncology #openaccess

000

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 22/09/2026

New online! 💉 What is the real-life effectiveness of #onabotulinumtoxinA for #migraine? Find out more in this cohort of 479 patients from 12 Polish specialized headache centers: journals.sagepub.com/doi/full/10....

011

Reposted by Jen L, PhD

Natural Product Communications @naturalproductcomm.bsky.social · 23/09/2026

Top Read Papers on Natural Product Communications - September 2026 6. In Vitro Antibacterial Activity of Crude Leaf Extracts of Pentas Schimperiana journals.sagepub.com/doi/10.1177/...

021

Reposted by Jen L, PhD

Natural Product Communications @naturalproductcomm.bsky.social · 23/09/2026

Top Read Papers on Natural Product Communications - September 2026 7. Phytochemical Evaluation and HPTLC Fingerprinting for the Standardization of Pachai Pakku Thailam, a Traditional Siddha Herbal Formulation for Non-Healing Ulcers journals.sagepub.com/doi/10.1177/...

031

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 23/09/2026

New online! 📰 Advances and challenges of the clinical implementation of the 2024 McDonald criteria for #MultipleSclerosis: Practical considerations and consensus recommendations from German experts journals.sagepub.com/doi/full/10....

012

Reposted by Jen L, PhD

Therapeutic Advances in Medical Oncology @tamedoncol.bsky.social · 23/09/2026

Evidence in NUT #carcinoma remains limited. This retrospective series of 25 H&N offers interesting insights into histologic differentiation and prognosis, including the adverse prognostic association of neuroendocrine differentiation. buff.ly/Evhy0A9

011

Reposted by Jen L, PhD

Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 24/09/2026

Mining may be an important occupational risk factor for TB. In a case-control study from Ethiopia (n=735), miners had >3× higher odds of active pulmonary TB (AOR 3.51, 95% CI 1.89–6.50). journals.sagepub.com/doi/full/10....

journals.sagepub.com

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

011

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 25/09/2026

New randomized controlled trial online! What is the effect of adding #atorvastatin or #rosuvastatin to #clopidogrel on preventing platelet activation and vascular events prevention in patients with acute large-vessel minor #stroke or TIA? journals.sagepub.com/doi/full/10....

011

Reposted by Jen L, PhD

Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 25/09/2026

TB stigma remains a major barrier to TB control. In this study of 385 patients in Napak district, Uganda, 43.1% reported high perceived stigma. Poor TB knowledge, inadequate social support, and secondary education were associated with higher stigma journals.sagepub.com/doi/full/10....

journals.sagepub.com

Prevalence of perceived stigma and associated factors among patients with tuberculosis in Napak district, Karamoja region, Uganda: A cross-sectional study - Victor Lomonyang, Saadick Mugerwa Ssentongo...

Background Tuberculosis (TB) remains a leading cause of infectious disease mortality globally. Stigma is a critical social determinant that undermines health-se...

011

Reposted by Jen L, PhD

Therapeutic Advances in Medical Oncology @tamedoncol.bsky.social · 25/09/2026

On #TAMO in 2025 🤰 Fertility preservation is a key component of care for young patients with #breast #cancer. Interesting evidence in this RW cohort where 54% underwent cryopreservation. More details here: journals.sagepub.com/doi/full/10.... @matteolambe

011

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 13/09/2026

A new Letter to the Editor online: Evolving #MultipleSclerosis criteria and the interpretation of research journals.sagepub.com/doi/full/10....

022

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 14/09/2026

What are the risk factors for relapse and poor outcomes in anti-LGI1 #encephalitis? Find out more here: journals.sagepub.com/doi/full/10....

021

Reposted by Jen L, PhD

Natural Product Communications @naturalproductcomm.bsky.social · 14/09/2026

Top Read Papers on Natural Product Communications - September 2026 5. Anticancer Mechanism of Thalictrum punduanum Root Extract Against Breast and Colorectal Cancer: A Network Pharmacology and Molecular Docking Simulation Insights journals.sagepub.com/doi/10.1177/...

021

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 15/09/2026

New Systematic Review online! What is the safety and cognitive efficacy of compounds derived from marine organisms in #Alzheimer's disease? journals.sagepub.com/doi/full/10....

011

Reposted by Jen L, PhD

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 15/09/2026

Congratulations to our Editorial Review Board member Maria Koulopoulou on presenting at #ERSCongress2026, with work focused on developing a competency framework for specialist ILD healthcare practitioners. #ILD #RespiratoryCare #RespiratoryResearch

011

Reposted by Jen L, PhD

Therapeutic Advances in Medical Oncology @tamedoncol.bsky.social · 15/09/2026

Management of #testicular #cancer still diverges from guidelines. Adj treatment remains common in stage I disease despite surveillance-based recommendations, while repeat imaging in stage IIA is inconsistently used. More details 👉️ buff.ly/3oeKQLu #oncology #realworld

011

Reposted by Jen L, PhD

Natural Product Communications @naturalproductcomm.bsky.social · 16/09/2026

💡 Editorial Review Board Member of the month - September 2026 This month, we interviewed Prof. Gunawan Indrayanto, an independent consultant who specializes in chemical, pharmaceutical, herbal analysis, metabolomics, and analytical method validation. Read more: journals.sagepub.com/page/npx/erb...

021

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 17/09/2026

What are the current practices to prevent and treat delirium after #stroke? Findings from German and Austrian stroke units: journals.sagepub.com/doi/full/10....

011

Reposted by Jen L, PhD

Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 17/09/2026

AMR strategies in LMICs focus on access, stewardship, and surveillance, but overlook whether antibiotic exposure is adequate. Subtherapeutic concentrations can contribute to Rx failure&resistance. TDM-guided dosing may optimize exposure, improve outcomes. journals.sagepub.com/doi/full/10....

journals.sagepub.com

Closing the therapeutic drug monitoring gap: A pragmatic, complementary lever against antimicrobial resistance in low- and middle-income countries - Mamunur Rahman, 2026

011

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 18/09/2026

What is the real-world safety and efficacy of #siponimod in secondary progressive #MultipleSclerosis? Findings from the RESYZE study: journals.sagepub.com/doi/full/10....

021

Reposted by Jen L, PhD

Therapeutic Advances in Medical Oncology @tamedoncol.bsky.social · 18/09/2026

On #TAMO in 2025. . End-of-life care is crucial in pancreatic #cancer. In this French cohort, 41% of pts received high-intensity EOL care, while #palliativecare involvement was associated with lower care intensity. . 👉 buff.ly/PyI4jy2

021

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 21/09/2026

📰 New research online by Cristina Duque and colleagues: 🧠 Is there a relationship between neurovascular coupling and clinical characteristics in #MultipleSclerosis? Find out more here: journals.sagepub.com/doi/full/10....

011

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 21/09/2026

New online! What is the association between neurovascular coupling and clinical characteristics and neuroimaging measures in early #MultipleSclerosis? journals.sagepub.com/doi/full/10....

022

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders @taneuroldisord.bsky.social · 12/09/2026

New Case Report online: Lamotrigine-induced Stevens-Johnson syndrome in a patient with mitochondrial encephalomyopathy journals.sagepub.com/doi/full/10....

011

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Bacterial AsmA Proteins Transfer Glycerophospholipids Between Membranes in Vitro Contact: The Journal of Inter-Organelle Communication @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #lipidtransfer #membranebiogenesis #bacteria #openaccess

010

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Biomarker-guided selection of intravesical therapy in high-risk non–muscle invasive bladder cancer: A contemporary review Therapeutic Advances in Urology @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #artificialintelligence #liquidbiopsy #cancerdetection #oncology #openaccess

021

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

GATES: A Lightweight Tool Automating Pathogenic Variant Discovery From Raw Whole-Exome Sequencing Data @cancerinformatics.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #thyroidcancer #genomevariants #detection #oncology #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

A phase II study of DFP-14323, a non-specific immunomodulator, in combination with low-dose afatinib as first-line therapy for common EGFR mutation-positive NSCLC @tamedoncol.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #lungcancer #cancertreatment #oncology #openaccess

010

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

In vitro pre-vascularized model of the human skin based on collagen hydrogel reinforced by fibrin-coated nanofibrous membrane Journal of Tissue Engineering @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #3Dmodel #biomimetic #vasculature #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Urine 5-HIAA and quality of life in neuroendocrine neoplasia. Is there an association? Rare Tumors @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #carcinoid #neoplasm #biomarker #cancer #oncology #openaccess

010

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

A review on toxicities of T-cell engager-based therapies in solid tumors @tamedoncol.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #immunotherapy #cancertreatment #oncology #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Perioperative treatment for muscle invasive bladder cancer in the era of immunotherapy Therapeutic Advances in Urology @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #MIBC #urothelialcancer #cancertreatment #oncology #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

NanoString profiling of DNA repair and apoptosis genes in testicular germ cell tumours with divergent chemotherapy outcomes @tamedoncol.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #testicularcancer #cancerresistance #oncology #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Antibody-drug conjugates and beyond in platinum-resistant ovarian cancer: A comprehensive review of emergent strategies @tamedoncol.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #ADCs #cancerresistance #targetedtherapy #oncology #openaccess

010

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Difficult conversations in bladder cancer survivorship: Integrating mental health and intimacy into routine urologic care Bladder Cancer @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #BCAN #cancercare #oncology #openaccess

012

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

An Immunological and Translational Framework for Interspecies Exogenic Liver Transplantation @celltransplant1992.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #liverdisease #therapy #grafts #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Spindle cell (sarcomatoid) squamous cell carcinoma of the esophagus: A case report and a review of the literature Rare Tumors @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #esophagealcancer #cancertreatment #oncology #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Clinical Utility of Circulating Tumor DNA Analysis in Pancreatic Ductal Adenocarcinoma Clinical Medicine Insights: Oncology @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #PDAC #ctDNA #cancerdetection #biomarker #openaccess

000

Jen L, PhD @drjkyl.bsky.social · 11/09/2026

Pulmonary carcinoid harboring a KRAS G12C mutation identified through comprehensive genomic profiling and responding to sotorasib: A case report Rare Tumors @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #neuroendocrinetumor #lung #cancer #oncology #openaccess

002

Reposted by Jen L, PhD

Natural Product Communications @naturalproductcomm.bsky.social · 10/09/2026

Natural Products for the Creation of Innovative Antimicrobials, Synbiotics, and Postbiotics Investigations on natural products of botanical and microbial origin as sources of antimicrobial agents & microbiota-directed formulations Deadline: December 11, 2026 journals.sagepub.com/topic/collec...

132

Reposted by Jen L, PhD

Natural Product Communications @naturalproductcomm.bsky.social · 10/09/2026

Natural Products from Underexplored Ecosystems Welcomes recent advances in the discovery, characterization, and application of bioactive compounds from underexplored, extreme and overlooked ecosystems environments. Submission deadline: December 22, 2026 journals.sagepub.com/topic/collec...

021